|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2005-6-6
|
|
pubmed:abstractText |
The purpose of this research was to determine the effect of intravenous adenosine on clinical outcomes and infarct size in ST-segment elevation myocardial infarction (STEMI) patients undergoing reperfusion therapy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
7
|
|
pubmed:volume |
45
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1775-80
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15936605-Adenosine,
pubmed-meshheading:15936605-Angioplasty, Balloon, Coronary,
pubmed-meshheading:15936605-Dose-Response Relationship, Drug,
pubmed-meshheading:15936605-Double-Blind Method,
pubmed-meshheading:15936605-Heart Failure,
pubmed-meshheading:15936605-Hospitalization,
pubmed-meshheading:15936605-Humans,
pubmed-meshheading:15936605-Myocardial Infarction,
pubmed-meshheading:15936605-Thrombolytic Therapy,
pubmed-meshheading:15936605-Vasodilator Agents
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II).
|
|
pubmed:affiliation |
Department of Medicine, George Washington University, Washington, DC, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
